2022 Nelson’s Pediatric Antimicrobial Therapy, 28th Edition (Original PDF from Publisher)
Original price was: $36.95.$6.00Current price is: $6.00.
Format: Publisher PDF
Category: Infectious Disease Pediatrics
published date: 11 Mar 22
By John S. Bradley MD, John D. Nelson MD, Dr. Barnett Elizabeth MD, Joseph B. Cantey MD MD MPH, David W. Kimberlin MD FAAP, Dr. Paul E Palumbo MD, Dr. Jason Sauberan PharmD, J. Howard Smart MD, Dr. William J Steinbach
Completely updated and revised, the 28th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens.
TOPICS INCLUDE
- Antimicrobial Therapy by Clinical Syndromes
- Antimicrobial Therapy for Neonates
- Choosing Among
- Antibiotics
- Antifungal Agents
- Antiviral Agents
- Antiparasitic Agents
- Oral Step-down Therapy for Serious Infections
- Prevention of Symptomatic Infection
- Approach to Antibiotic Allergies
- Antibiotic Stewardship
New in the 28th Edition
- Updated recommendations on acute hematogenous osteomyelitis, based on newly published guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America, including information on a decrease in the incidence of MRSA infections, allowing the recommendation of cefazolin, again, in empiric therapy for most pediatric bone infections
- Updated recommendations on influenza treatment and prophylaxis, reflecting American Academy of Pediatrics guidance for 2021–2022
- Ceftazidime/avibactam now preferred over fluoroquinolones for treatment of Klebsiella pneumoniae carbapenemase–producing enteric bacilli, if susceptible
- Cefiderocol, a new iron-binding siderophore cephalosporin class, recently approved in adults for treatment of many drug-resistant pathogens, particularly Acinetobacter, Stenotrophomonas, and Pseudomonas; under study in children
- New dosing for posaconazole suspension formulation
- New approaches to mucormycosis
- Added baloxavir for children 12+ years old
- Online updates of COVID-19 therapies once emergency use authorization in children at http://www.aap.org/nelsons
- Updated Nelson’s app also available
Product Details
- Publisher : American Academy of Pediatrics; Twenty-eighth edition (April 15, 2022)
- Language : English
- Paperback : 366 pages
- ISBN-10 : 1610025644
- ISBN-13 : 978-1610025645
- ISBN-13 : 9781610025645
- eText ISBN: 9781610025652
- Reading age : Baby and up
DETAILS
-
Publisher
-
Language
-
ISBN9781610025645
-
Original Link
-
Category